NFE2L2 and diabetes mellitus: Extensive literature has demonstrated the beneficial effects of Nrf2 activation in other pathologies, such as fatty liver disease [265], cardiovascular diseases [266], diabetes [267], neurodegenerative diseases, as well as Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic disease characterized by accelerated aging [268,269].